¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28
±³À°ÀÏÀÚ : 2024-06-28
±³À°Àå¼Ò : ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï ÄÚ¿¢½º B1 ´ÙÀ̾Ƹóµå·ë

±³À°ÁÖÁ¦ : Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ
´ã´çÀÚ : ±èÈ£Á¤
¿¬¶ôó : 055-910-2187  

À̸ÞÀÏ : ksimd2014@naver.com

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 70,000¿ø  

ºñ°í "»çÀüµî·Ï(ȸ   ¿ø): Àü¹®ÀÇ 4¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 3¸¸¿ø, ±âŸ 4¸¸¿ø

»çÀüµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 6¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 5¸¸¿ø, ±âŸ 6¸¸¿ø 

ÇöÀåµî·Ï(ȸ   ¿ø): Àü¹®ÀÇ 5¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 4¸¸¿ø, ±âŸ 5¸¸¿ø 

ÇöÀåµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 7¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 6¸¸¿ø, ±âŸ 7¸¸¿ø" 


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 10:00~10:40 Transforming the Newborn Screening Program in Tokyo: Improving Children Kimihiko Oishi(Chair and Professor of the Department of Pediatrics at the Jikei University School of Medicine)

±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 10:40~11:20 Health care transition from pediatric to adult care for the patients of inherited metabolic diseases Mitsuru Kubota(ational Center for Child Health and Development, Japan)

ÈÞ½Ä 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 11:20~11:30 Break Time ()

±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 11:30~12:00 Phase I,II,III clinical trial of idursulfatase beta in Hunter syndrome; from the beginning to the end Áøµ¿±Ô(³ëº§Æĸ¶)

±³À°½Ã°£ 06¿ù 28ÀÏ 12:00~12:30 Translational and clinical development of cell therapy for Charcot-Marie-Tooth type I disease Á¤¼ºÃ¶(ÀÌÈ­ÀÇ´ë)

½Ä»ç 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 12:30~13:30 ½Ä»ç ()

±âŸ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 13:30~14:30 oral presentation(Japan & Korea) ()

ÈÞ½Ä 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 14:30~14:50 Break Time & Poster rounding ()

±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 14:50~15:20 Recognition of alpha mannosidosis - How to diagnose and how to treat Christina Lampe(University Hospital of Giessen, Germany)

±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 15:20~15:50 Pediatric phenylketonuria: ex-vivo cell therapy Á¤Àç¹Î(¼­¿ï¿©´ë)

ÈÞ½Ä 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 15:50~16:00 Break Time ()

±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:00~16:20 Treatment and management strategies for primary mitochondrial disease ³ªÁöÈÆ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:20~16:40 Pre-implantation Genetic Testing in primary mitochondrial disease ¿ÀÁö¿µ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:40~17:00 Chaperone therapy in IMD À̹üÈñ(¿ï»êÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29
´ÙÀ½±Û Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 39 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 36 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 32 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 28 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 32 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 59 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 18 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 27 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 24 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 26 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 24 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 24 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 29 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 30 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷